Platelet MicroRNA-484 as a Novel Diagnostic Biomarker for Acute Coronary Syndrome
Laboratory Medicine · 2023
DOI: 10.1093/labmed/lmac102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2023. Verfasst von Parisa Masoodi Khabar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, MicroRNAs, Coronary Artery Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Shahid Beheshti University of Medical Sciences.
Abstract (Originalsprache)
Objective
Platelet microRNAs (miRs) have been indicated as a diagnostic biomarker in various diseases, including acute coronary syndrome (ACS). This study aimed to investigate the expression of miR-223-5p, miR-126-5p, miR-484, and miR-130a-3p in individuals with coronary artery disease (CAD).
Methods
Forty subjects with CAD and 13 healthy individuals were under study. The expression of miR-223-5p, miR-126-5p, miR-484, and miR-130a-3p was measured in platelets by quantitative reverse transcription–polymerase chain reaction. The relationship between miRNA expression and various parameters of the subjects was analyzed using analysis of variance and Spearman and t-tests.
Results
The miR-484 expression was significantly upregulated in the ACS subjects (P = .0097). Moreover, miR-484 had diagnostic value for screening subjects with unstable angina vs controls (area under the curve [AUC] = 0.978, 95% confidence interval [CI] 0.92–1, P = .0006) and NSTEMI patients versus controls (AUC = 0.910, 95% CI 0.74–1, P = .005).
Conclusion
The results of this study indicate that the upregulated expression of miR-484 in ACS patients might be used as a diagnostic biomarker in ACS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Cardiology, Taleghani General Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Hematopoietic Stem Cell Research Centre - Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Förderung
- Shahid Beheshti University of Medical Sciences
Zitieren
APA
Masoodi Khabar, P., Ghydari, M. E., Vazifeh Shiran, N., Shirazy, M., & Hamidpour, M. (2023). Platelet MicroRNA-484 as a Novel Diagnostic Biomarker for Acute Coronary Syndrome. Laboratory Medicine. https://doi.org/10.1093/labmed/lmac102
Vancouver
Masoodi Khabar P, Ghydari ME, Vazifeh Shiran N, Shirazy M, Hamidpour M. Platelet MicroRNA-484 as a Novel Diagnostic Biomarker for Acute Coronary Syndrome. Laboratory Medicine. 2023. doi:10.1093/labmed/lmac102
BibTeX
@article{MasoodiKhabar2023,
author = {Masoodi Khabar, Parisa and Ghydari, Mohamad Esmail and Vazifeh Shiran, Nader and Shirazy, Mohammadreza and Hamidpour, Mohsen},
title = {Platelet MicroRNA-484 as a Novel Diagnostic Biomarker for Acute Coronary Syndrome},
journal = {Laboratory Medicine},
year = {2023},
doi = {10.1093/labmed/lmac102}
}
EUVIMED